|
|
|
|
|
|
|
|
130th MAINE LEGISLATURE |
|
|
LD 1115 |
|
LR 1215(03) |
|
|
|
An Act To Improve
Access to HIV Prevention Medications |
|
Fiscal Note for
Bill as Amended by Committee Amendment " " |
|
Committee: Health Coverage, Insurance and
Financial Services |
|
Fiscal Note Required: Yes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Note |
|
|
|
FY 2021-22 |
FY 2022-23 |
Projections FY 2023-24 |
Projections FY 2024-25 |
Appropriations/Allocations |
|
|
|
|
|
|
Other Special Revenue Funds |
|
$43,839 |
$55,675 |
$58,640 |
$61,783 |
|
|
|
|
|
|
|
Transfers |
|
|
|
|
|
|
Other Special Revenue Funds |
|
$0 |
$0 |
$0 |
$0 |
|
|
|
|
|
|
|
Fiscal Detail
and Notes |
|
|
|
|
|
|
The bill includes
Other Special Revenue Funds allocations to the Department of Professional and
Financial Regulation of $43,839 in fiscal year 2021-22 and $55,675 in fiscal
year 2022-23 to implement the requirements of this legislation within the
Office of Professional and Occupational Licensing, Maine Board of
Pharmacy. |
|
Of this amount,
the bill includes Other Special Revenue Funds allocations to the Licensing
and Enforcement program of $41,110 in fiscal year 2021-22 and $52,328 in
fiscal year 2022-23 to establish one half-time Regulatory Health Compliance
position and related All Other costs to manage the anticipated increase in
workload associated with the regulation of pharmacists authority to dispense
HIV prevention drugs. Additionally, the bill includes Other Special Revenue
Funds allocations to the Administrative Services Division of $2,729 in fiscal
year 2021-22 and $3,347 in fiscal year 2022-23 for technology-related costs
associated with establishing the Regulatory Health Compliance position. The Office of Professional and Occupational
Licensing will transfer funds from its Licensing and Enforcement program
(which includes funds for the Maine Board of Pharmacy) to the Administrative
Services Division to fund the allocations. |
|
The Maine Board
of Pharmacy within the Office of Professional and Occupational Licensing has
sufficient resources available to support the cost of this legislation
without raising fees through the 2022-2023 biennium. However, fees may need to be increased in
future biennia if the current fee structure does not generate sufficient
revenue to cover the cost of this legislation. |
|
|
|
|
|
|
|